Carolyn Bertozzi

National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC.

The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA.

The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care.

The American Society for Biochemistry and Molecular Biology, Inc. is an international non-profit scientific and educational organization based in Bethesda, MD. With over 11,000 members, the society is one of the largest molecular life science societies in the world. The society serves the scientific community through the publication of peer-reviewed journals and science news, organization of scientific meetings, advocacy for funding of basic research and education, support of career development and science education at all levels, promoting the diversity of individuals entering the scientific workforce, and celebrating important contributions and achievements in science and technology made by black scientists. The society also honors an outstanding scientist who has shown a sustained commitment to breaking down local and/or systemic barriers against scientists and students from historically marginalized or excluded groups. Founded in 1906, the society's mission is to advance the science of biochemistry and molecular biology and promote the understanding of the molecular nature of life processes.

The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.

Accademia Nazionale dei Lincei engages in the provision of cultural studies. It carries out research activities, national and international conferences, meetings and seminars, offers awards and grants, and provides advice to public institutions. The company was founded by Federico Cesi in 1603 and is headquartered in Rome, Italy.

Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA.

The National Academy of Inventors operates as a business association that promotes investors. The private company is based in Tampa.

Grace Science Foundation is a biotechnology company that was founded in 2017 by Matt Wilsey and Dr. Carolyn Bertozzi. The private company is based in San Francisco, CA. The company focuses on developing novel therapies based on the function of NGLY1, a key enzyme involved in proteostasis. Grace Science Foundation's deep knowledge of the NGLY1 pathway enables them to identify new ways of treating NGLY1 deficiency as well as more common diseases.

Venn Biosciences Corp. engages in developing an artificial intelligence-driven mass spectrometry discovery and validation platform. Its products include VENN Vista, a glycoproteomic analysis; OpenPIP software, a neural network for automated mass spectrometry peak integration; and cancer liquid biopsy. The company was founded by Lieza Denan, Aldo Carrascoso, Carlito B. Lebrilla, and Carolyn R. Bertozzi in June 2017 and is headquartered in South San Francisco, CA.

Lycia Therapeutics, Inc. is a biotechnology company, which engages in the developing technology that utilizes lysosome-targeting chimeras. It uses LYTACs platform to discover and provide therapeutics that degrade extracellular and membrane-bound proteins that drive a range of difficult-to treat diseases, including cancers and autoimmune conditions. The company was founded by Carolyn R. Bertozzi in 2019 and is headquartered in San Diego, CA.

Enable Biosciences, Inc. is a diagnostics company based in the United States. The private company is based in the United States. The American company develops and deploys bioassays for type 1 diabetes, COVID-19, and food allergy using licensed technology from UC. Enable Biosciences operates a CLIA certified high-complexity clinical reference laboratory and research facility. The company's proprietary diagnostics platform enables the ultrasensitive detection of biomarkers at the earliest stages of disease for optimal treatment timing. The company's fully automated high-throughput ultrasensitive and highly specific multiplex antibody detection analyzer uses its novel antibody detection by agglutination PCR (ADAP) chemistry to service clients in the infectious disease, autoimmunity, and allergy spaces. Enable has produced the independently-assessed world's best performing serologic tests for type 1 diabetes and HIV in oral fluid and other infectious diseases including Zika and Dengue. The company was founded by Jason Tsai, Carolyn R. Bertozzi, Peter Robinson, and David Seftel, with David Seftel serving as the CEO since incorporation.

OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA.

Firefly Bio, Inc. is an American company located in South San Francisco, CA. The firm specializes in degrader antibody conjugates which combine the unique strengths of ADCs with selective protein degraders. It was founded by Carolyn R. Bertozzi, John Flygare and Bernhard Geierstanger. Scott Hirsch is currently the CEO of the company.